World's largest chemical company in term of sales, BASF from Germany is all set to take over the Norway's Pronova BioPharma PRON.
Pronova is currently a leading supplier of omega-3 fatty acids which will now be bought by the German based BASF. The deal will be valued $844 million that mounts to 4.85 billion Norwegian kroner.
As described by BASF, Pronova is the leader in research, development and manufacturing the omega-3 fatty acids. The market of these acids is growing since they are very much beneficial for health.
The deal is expected to close within the first three months next year. The chemical giant BASF anticipates a good future in the field of omega-3 fatty acids. Fatty acids are believed to be beneficial for the cardiovascular system of humans.
BASF made an official announcement this Wednesday that it aims to be the number one in the production of omega-3 fatty acids. "Due to this acquisition BASF should become the leading producer in the fast growing market for concentrated omega-3 fatty acids and cover the entire range of the omega-3 fatty acids", said an analyst, Nadeshda Demidova from Equinet Bank.
Critics see the purchase amount as really small since Pronova's turnover was summed up to _230 million the previous year.
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).